4//SEC Filing
Ciappenelli Robert D. 4
Accession 0001399529-21-000164
CIK 0001399529other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 9:02 PM ET
Size
6.9 KB
Accession
0001399529-21-000164
Insider Transaction Report
Form 4
Ciappenelli Robert D.
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-13$22.58/sh+8,856$199,968→ 12,629 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-12-13−8,856→ 76,144 totalExercise: $22.58Exp: 2030-01-07→ Common Stock (8,856 underlying)
Footnotes (1)
- [F1]The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2020, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the reporting person's continued service with the issuer through each applicable vesting date.
Documents
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeother
Related Parties
1- filerCIK 0001778786
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 9:02 PM ET
- Size
- 6.9 KB